Stock Upgrades: Abbott Laboratories Shows Rising Relative StrengthInvestors Business Daily • 07/21/20
Abbott Laboratories (ABT) CEO, Robert Ford on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/16/20
Abbott Labs' stock gains after profit, revenue and full-year outlook top expectationsMarket Watch • 07/16/20
Why Big Pharma's $1 Billion Bet to Prevent a Bacterial Pandemic Matters for YouThe Motley Fool • 07/14/20
Abbott Labs, Edwards Lifesciences settle patent dispute over heart valve productsMarket Watch • 07/13/20
Abbott Agrees to Global Transcatheter Litigation Settlement with Edwards LifesciencesPRNewsWire • 07/13/20
Have $5,000? 3 Coronavirus Stocks You Can Buy in July Without Losing Any SleepThe Motley Fool • 07/12/20
Abbott Laboratories Shows Improved Relative Strength; Still Shy Of BenchmarkInvestors Business Daily • 07/08/20
Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote MonitoringPRNewsWire • 07/06/20